Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Familial risk for attention-deficit/hyperactivity disorder and related behaviors in toddlerhood are preliminarily associated with altered frontoparietal development in infancy measured by functional near-infrared spectroscopy

Front Neurosci. 2026 Oct 20;20:1919928. doi: 10.3389/fnins.2026.1919928. eCollection 2026.ABSTRACTINTRODUCTION: Attention-Deficit/Hyperactivity Disorder (ADHD) is a common childhood neurodevelopmental disorder associated with impairments across the lifespan. Children...

Centanafadine: First Approval

Drugs. 2026 Oct 24. doi: 10.1007/s40265-026-02411-0. Online ahead of print.ABSTRACTCentanafadine (SIMTRIYO®) is a first-in-class, sustained-release norepinephrine, dopamine and serotonin reuptake inhibitor and central nervous system...
close chatgpt icon
ChatGPT

Enter your request.

← CME/CPD